Case Study: Global Pharmaceutical Company removes £millions in data risk with Exonar Reveal

Global Pharmaceutical Company removes £3.8m in data risk with Exonar

The customer, a global pharmaceutical company, faced a significant data governance challenge following a merger. The new organization was concerned about inheriting and inadvertently mixing sensitive data, including corporate information, intellectual property, and personal health records from the two former entities. It turned to Exonar and used its Exonar Reveal product to discover and manage this risk within its unstructured data estates.

Using Exonar Reveal, the company indexed its data to discover tens of thousands of files containing sensitive information downloaded from databases; a large amount of data was also found to be outdated. This discovery enabled a massive remediation effort where files were separated or deleted. Exonar helped the company remove £3.8 million in risk, reduce storage costs by £1 million, and improve its data review team's efficiency by 400%.